Drug intelligence / Profile preview

18F-FHBG

Development stage
Unknown
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

**18F-FHBG** is a fluorine-18-labeled acycloguanosine derivative used as a positron emission tomography (PET) imaging agent. It acts as a specific substrate for herpes simplex virus type 1 thymidine kinase (HSV1-tk), which phosphorylates and traps the compound in cells expressing this gene. This property enables noninvasive imaging of HSV1-tk gene expression, making it valuable for monitoring gene transfer efficiency and tracking therapeutic transgenes in vivo, particularly in the context of cancer gene therapy and cell-based therapies. The tracer demonstrates favorable pharmacokinetics, rapid blood clearance, low background signal, biosafety, and acceptable radiation dosimetry in humans[2][3][4]. It does not cross the blood-brain barrier under normal conditions[4].

Other names
9-(4-(18F)Fluoro-3-(hydroxymethyl)butyl)guanine
02

Targets

HSV-TK (Herpes simplex virus type 1 thymidine kinase (HSV1-TK))

Beyond the preview

Go deeper on 18F-FHBG.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 18F-FHBG.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call